| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $38.4M | +10.2% |
| Cost of Revenue | $14.2M | -3.5% |
| Gross Profit | $24.2M | +20.2% |
| R&D Expense | $26.2M | -1.4% |
| SG&A Expense | $17.1M | -5.5% |
| Operating Income | -$41.3M | +14.3% |
| Pre-tax Income | -$39.0M | +14.8% |
| Income Tax | $44K | -78.4% |
| Net Income | -$39.0M | +15.1% |
| EPS (Basic) | -$1.83 | +19.0% |
| EPS (Diluted) | -$1.83 | +19.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.4M | -42.4% |
| Short-term Investments | $16.4M | +185.8% |
| Accounts Receivable | $6.4M | +10.3% |
| Current Assets | $39.3M | +6.1% |
| Total Assets | $75.8M | -5.9% |
| Current Liabilities | $9.1M | -27.0% |
| Total Liabilities | $14.4M | -22.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.6M | -20.8% |
| Capital Expenditures | $212K | -32.5% |
| Investing Cash Flow | -$11.3M | -189.8% |
| Financing Cash Flow | $28.8M | +1142.2% |
| Free Cash Flow | -$26.8M | -20.1% |
| Stockholders' Equity |
| $61.4M |
| -0.9% |